265 related articles for article (PubMed ID: 15369821)
1. Homotropic cooperativity of monomeric cytochrome P450 3A4 in a nanoscale native bilayer environment.
Baas BJ; Denisov IG; Sligar SG
Arch Biochem Biophys; 2004 Oct; 430(2):218-28. PubMed ID: 15369821
[TBL] [Abstract][Full Text] [Related]
2. Cooperativity in oxidations catalyzed by cytochrome P450 3A4.
Ueng YF; Kuwabara T; Chun YJ; Guengerich FP
Biochemistry; 1997 Jan; 36(2):370-81. PubMed ID: 9003190
[TBL] [Abstract][Full Text] [Related]
3. Influence of glutathione on the catalytic activity of reconstituted cytochrome P450 3A4.
Kim BR; Kim DH
Biochem Biophys Res Commun; 1998 Jan; 242(1):209-12. PubMed ID: 9439637
[TBL] [Abstract][Full Text] [Related]
4. Dual role of human cytochrome P450 3A4 residue Phe-304 in substrate specificity and cooperativity.
Domanski TL; He YA; Harlow GR; Halpert JR
J Pharmacol Exp Ther; 2000 May; 293(2):585-91. PubMed ID: 10773032
[TBL] [Abstract][Full Text] [Related]
5. Using Nanodiscs to create water-soluble transmembrane chemoreceptors inserted in lipid bilayers.
Boldog T; Li M; Hazelbauer GL
Methods Enzymol; 2007; 423():317-35. PubMed ID: 17609138
[TBL] [Abstract][Full Text] [Related]
6. Elucidation of distinct ligand binding sites for cytochrome P450 3A4.
Hosea NA; Miller GP; Guengerich FP
Biochemistry; 2000 May; 39(20):5929-39. PubMed ID: 10821664
[TBL] [Abstract][Full Text] [Related]
7. Measurement of 4-hydroxylation of ifosfamide in human liver microsomes using the estimation of free and protein-bound acrolein and codetermination of keto- and carboxyifosfamide.
Preiss R; Schmidt R; Baumann F; Hanschmann H; Hauss J; Geissler F; Pahlig H; Ratzewiss B
J Cancer Res Clin Oncol; 2002 Jul; 128(7):385-92. PubMed ID: 12136253
[TBL] [Abstract][Full Text] [Related]
8. Interactions of mammalian cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b(5) enzymes.
Shimada T; Mernaugh RL; Guengerich FP
Arch Biochem Biophys; 2005 Mar; 435(1):207-16. PubMed ID: 15680923
[TBL] [Abstract][Full Text] [Related]
9. Co-incorporation of heterologously expressed Arabidopsis cytochrome P450 and P450 reductase into soluble nanoscale lipid bilayers.
Duan H; Civjan NR; Sligar SG; Schuler MA
Arch Biochem Biophys; 2004 Apr; 424(2):141-53. PubMed ID: 15047186
[TBL] [Abstract][Full Text] [Related]
10. Applications of phospholipid bilayer nanodiscs in the study of membranes and membrane proteins.
Nath A; Atkins WM; Sligar SG
Biochemistry; 2007 Feb; 46(8):2059-69. PubMed ID: 17263563
[TBL] [Abstract][Full Text] [Related]
11. Heterotropic cooperativity of cytochrome P450 3A4 and potential drug-drug interactions.
Tang W; Stearns RA
Curr Drug Metab; 2001 Jun; 2(2):185-98. PubMed ID: 11469725
[TBL] [Abstract][Full Text] [Related]
12. The use of liposomes in the study of drug metabolism: a method to incorporate the enzymes of the cytochrome p450 monooxygenase system into phospholipid, bilayer vesicles.
Reed JR
Methods Mol Biol; 2010; 606():11-20. PubMed ID: 20013386
[TBL] [Abstract][Full Text] [Related]
13. [Regulation of the catalytic activity of the monooxygenase enzyme system depending of the substrate structure and phospholipid composition of the model membrane].
Kiselev PA; Garda G; Finch SA; Stir A; Khatyleva SIu; Akhrem AA
Biokhimiia; 1990 Nov; 55(11):2058-71. PubMed ID: 2085619
[TBL] [Abstract][Full Text] [Related]
14. Cooperativity in cytochrome P450 3A4: linkages in substrate binding, spin state, uncoupling, and product formation.
Denisov IG; Baas BJ; Grinkova YV; Sligar SG
J Biol Chem; 2007 Mar; 282(10):7066-76. PubMed ID: 17213193
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis of P450 inhibition and activation: implications for drug development and drug therapy.
Szklarz GD; Halpert JR
Drug Metab Dispos; 1998 Dec; 26(12):1179-84. PubMed ID: 9860924
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of cytochrome P450 reactions by apo-cytochrome b5: evidence against transfer of heme from cytochrome P450 3A4 to apo-cytochrome b5 or heme oxygenase.
Yamazaki H; Shimada T; Martin MV; Guengerich FP
J Biol Chem; 2001 Aug; 276(33):30885-91. PubMed ID: 11413149
[TBL] [Abstract][Full Text] [Related]
17. The bacterial P450 BM3: a prototype for a biocatalyst with human P450 activities.
Yun CH; Kim KH; Kim DH; Jung HC; Pan JG
Trends Biotechnol; 2007 Jul; 25(7):289-98. PubMed ID: 17532492
[TBL] [Abstract][Full Text] [Related]
18. Membrane-embedded substrate recognition by cytochrome P450 3A4.
Hackett JC
J Biol Chem; 2018 Mar; 293(11):4037-4046. PubMed ID: 29382727
[TBL] [Abstract][Full Text] [Related]
19. Mechanism-based inactivation of cytochrome P450 3A4 by L-754,394.
Lightning LK; Jones JP; Friedberg T; Pritchard MP; Shou M; Rushmore TH; Trager WF
Biochemistry; 2000 Apr; 39(15):4276-87. PubMed ID: 10757976
[TBL] [Abstract][Full Text] [Related]
20. Direct solubilization of heterologously expressed membrane proteins by incorporation into nanoscale lipid bilayers.
Civjan NR; Bayburt TH; Schuler MA; Sligar SG
Biotechniques; 2003 Sep; 35(3):556-60, 562-3. PubMed ID: 14513561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
